Bolus MPTP Injection in Aged Mice to Mimic Parkinson Disease: Effects of Low-Dose Antioxidant Treatment with Fullerene (C60) and Fullerenol (C60(OH)24).

Biomedicines · 2025 · PMC12561033 · PMID 41153708

Europe PMC DOI

hedged sentence

0.0584

closest p · 1.2× alpha

0.0584

boldest claim

The sentences

a strong trendp = 0.0584so close (0.05 < p ≤ 0.1)

Similarly, a strong trend for MPTP effect was shown for latency to descend (F = 3.802, p = 0.0584, two-way ANOVA; Figure 2 G), but not for treatment or interaction (F = 0.843, p = 0.438 and F = 0.855, p = 0.433, respectively).

also in 1,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Bolus MPTP Injection in Aged Mice to Mimic Parkinson Disease: Effects of Low-Dose Antioxidant Treatment with Fullerene (C&lt;sub&gt;60&lt;/sub&gt;) and Fullerenol (C&lt;sub&gt;60&lt;/sub&gt;(OH)&lt;sub&gt;24&lt;/sub&gt;).

The sentences

Bolus MPTP Injection in Aged Mice to Mimic Parkinson Disease: Effects of Low-Dose Antioxidant Treatment with Fullerene (C<sub>60</sub>) and Fullerenol (C<sub>60</sub>(OH)<sub>24</sub>).